Catalpol protects rat pheochromocytoma cells against oxygen and glucose deprivationinduced injury

Neurological Research

Volumn 30, Issue 1, 2008, Pages 106-112

  Wang, Zhuo ^a   An, Li Jia ^a   Duan, Yan Long ^a   Li, Ya Chen ^a   Jiang, Bo ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Bcl 2; Caspase 3; Catalpol; Ischemia; PC12; ROS

Indexed keywords

CASPASE 3; CATALPOL; GLUCOSE; GLUCOSIDE; GLUTATHIONE PEROXIDASE; HERBACEOUS AGENT; IRIDOID; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL; ANOXIA; APOPTOSIS; ARTICLE; CELL COUNT; CELL STRAIN; DOSE RESPONSE; DRUG EFFECT; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; RAT;

ANIMALS; ANOXIA; APOPTOSIS; CASPASE 3; CELL COUNT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; GLUCOSE; GLUCOSIDES; GLUTATHIONE PEROXIDASE; IRIDOIDS; MEMBRANE POTENTIAL, MITOCHONDRIAL; PC12 CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 45549090068     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/016164107X229894     Document Type: Article

References (39)

1. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999; 79: 1431-1568.
2. Abu-Raya S, Trembovler V, Shohami E, et al. A tissue culture ischemic device to study eicosanoid release by pheochromocytoma PC12 cultures. J Neurosci Methods 1993; 50: 197-203.
3. Mattson MP, Duan W, Pedersen WA, et al. Neurodegenerative disorders and ischemic brain diseases. Apoptosis 2001; 6: 69-81.
4. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999; 341: 233-249.
5. Iijima T. Mitochondrial membrane potential and ischemic neuronal death. Neurosci Res 2006; 55: 234-243.
6. Lim ML, Lum MG, Hansen TM, et al. On the release of cytochrome c from mitochondria during cell death signaling. J Biomed Sci 2002; 9: 488-506.
7. Crompton M. Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis. Curr Opin Cell Biol 2000; 12: 414-419.
8. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 1997; 275: 1129-1132.
9. Ismailoglu UB, Saracoglu I, Harput US, et al. Effects of phenylpropanoid and iridoid glycosides on free radical-induced impairment of endothelium-dependent relaxation in rat aortic rings. J Ethnopharmacol 2002; 79: 193-197.
10. Jiang B, Liu JH, Bao YM, et al. Catalpol inhibits apoptosis in hydrogen peroxide-induced PC12 cells by preventing cytochrome c release and inactivating of caspase cascade. Toxicon 2004; 43: 53-59.
11. Li DQ, Li Y, Liu Y, et al. Catalpol prevents the loss of CA1 hippocampal neurons and reduces working errors in gerbils after ischemia-reperfusion injury. Toxicon 2005; 46: 845-851.
12. Mosmann T. Rapid colorimetric assay for cellular growth and survivals: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
13. Vian L, Vincent J, Maurin J, et al. Comparison of three in vitro cytotoxicity assays for estimating surfactant ocular irritation. Toxicol In Vitro 1995; 9: 185-190.
14. Zamzami N, Maisse C, Metivier D, et al. Measurement of membrane permeability and permeability transition of mitochondria. Methods Cell Biol 2001; 65: 147-158.
15. Palmeira CM, Moreno AJ, Madeira VM, et al. Continuous monitoring of mitochondrial membrane potential in hepatocyte cell suspensions. J Pharmacol Toxicol Methods 1996; 35: 35-43.
16. Tabakman R, Lazarovici P, Kohen R. Neuroprotective effects of carnosine and homocarnosine on pheochromocytoma PC12 cells exposed to ischemia. J Neurosci Res 2002; 68: 463-469.
17. Wie MB, Cho YJ, Jhoo WK, et al. Phenidone attenuates oxygen/ glucose deprivation-induced neurotoxicity by antioxidant and antiapoptotic action in mouse cortical cultures. Neurosci Lett 1999; 272: 91-94.
18. Meloni BP, Majda BT, Knuckey NW. Evaluation of preconditioning treatments to protect near-pure cortical neuronal cultures from in vitro ischemia induced acute and delayed neuronal death. Brain Res 2002; 928: 69-75.
19. Beal MF. Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci 2000; 23: 298-304.
20. Murphy AN, Fiskum G, Beal MF. Mitochondria in neurodegeneration: Bioenergetic function in cell life and death. J Cereb Blood Flow Metab 1999; 19: 231-245.
21. Ravagnan L, Roumier T, Kroemer G. Mitochondria, the killer organelles and their weapons. J Cell Physiol 2002; 192: 131-137.
22. Gürsoy-Özdemir Y, Can A, Dalkara T. Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 2004; 35: 1449-1453.
23. Smeitink JA, van den Heuvel LW, Koopman WJ, et al. Cell biological consequences of mitochondrial NADH: Ubiquinone oxidoreductase deficiency. Curr Neurovasc Res 2004; 1: 29-40.
24. Fleury C, Mignotte B, Vayssiere JL. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 2002; 84: 131-141.
25. Polster BM, Fiskum G. Mitochondrial mechanisms of neural cell apoptosis. J Neurochem 2004; 90: 1281-1289.
26. Park JL, Lucchesi BR. Mechanisms of myocardial reperfusion injury. Ann Thorac Surg 1999; 68: 1905-1912.
27. Islekel S, Islekel H, Guner G, et al. Alterations in superoxide dismutase, glutathione peroxidase and catalase activities in experimental cerebral ischemia-reperfusion. Res Exp Med (Berl) 1999; 199: 167-176.
28. Nakagawa T, Zhu H, Morishima N, et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-b. Nature 2000; 403: 98-103.
29. Cheng Y, Deshmukh M, D'Costa A, et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 1998; 101: 1992-1999.
30. Nakajima W, Ishida A, Lange MS, et al. Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J Neurosci 2000; 20: 7994-8004.
31. Petit PX, Goubern M, Diolez P., et al. Disruption of the outer mitochondrial membrane as a result of large amplitude swelling: The impact of irreversible permeability transition. FEBS Lett 1998; 426: 111-116.
32. Qian T, Nieminen AL, Herman B, et al. Mitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes. Am J Physiol 1997; 273: C1783-C1792.
33. Tatton WG, Olanow CW. Apoptosis in neurodegenerative diseases: The role of mitochondria. Biochim Biophys Acta 1999; 1410: 195-213.
34. Nicholls DG, Budd SL. Mitochondria and neuronal survival. Physiol Rev 2000; 80: 315-360.
35. Kluck RM, Martin SJ, Hoffman BF, et al. Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J 1996; 16: 4639-4649.
36. Shimizu S, Eguchi Y, Kamiike W, et al. Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene 1996; 13: 21-29.
37. Shimizu S, Eguchi Y, Kamiike W, et al. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc Natl Acad Sci USA 1998; 95: 1455-1459.
38. Cory S, Adams JM. The Bcl2 family: Regulators of the cellular lifeor- death switch. Nat Rev Cancer 2000; 2: 647-656.
39. Adams JM, Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 2001; 26: 61-66